---
title: "ZXFC: Shareholder Zhongwei Investment has cumulatively reduced its holdings by 3.25 million shares of the company"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256733895.md"
description: "ZXFC announced that from August 29, 2025, to September 9, 2025, Zhongwei Investment reduced its holdings by a total of 3,250,414 shares, accounting for 0.99869% of the company's total share capital. After this equity change, Zhongwei Investment holds a total of 22,600,686 shares, with its shareholding ratio decreasing from 7.94274% to 6.94405%"
datetime: "2025-09-10T11:37:55.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256733895.md)
  - [en](https://longbridge.com/en/news/256733895.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256733895.md)
generator: "portal-rs"
---

# ZXFC: Shareholder Zhongwei Investment has cumulatively reduced its holdings by 3.25 million shares of the company

ZXFC announced that from August 29, 2025, to September 9, 2025, Zhongwei Investment reduced its holdings by a total of 3,250,414 shares, accounting for 0.99869% of the company's total share capital. After this equity change, Zhongwei Investment holds a total of 22,600,686 shares in the company, with its shareholding ratio decreasing from 7.94274% to 6.94405%

### Related Stocks

- [002915.CN](https://longbridge.com/en/quote/002915.CN.md)

## Related News & Research

- [Money Managers Turn Bullish On China Despite Mounting Economic Woes](https://longbridge.com/en/news/296554795.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [Cell C publishes FY2026 annual report](https://longbridge.com/en/news/296585950.md)
- [Exxaro Resources Non-GAAP EPS of R 13.77, revenue of R 22.1B; reaffirms FY 2026 outlook](https://longbridge.com/en/news/296457906.md)
- [US Cocoa Futures (COCOA-F) Surges on Aug 19: Key Factors to Watch](https://longbridge.com/en/news/296344984.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**